Hdl Handle:
Synthetic cannabinoids and cathinones: prevalence and markets
Bretteville-Jensen, Anne Line; Tuv, Silja Skogstad; Bilgrei, Ola Røed; Fjeld, Bente; Bachs, Liliana
Bretteville-Jensen AL, Tuv SS, Bilgrei OR,Fjeld B, Bachs L: Synthetic cannabinoids and cathinones: Prevalence and markets; Forensic sci rev 25:7;2013

Full metadata record

DC FieldValue Language
dc.contributor.authorBretteville-Jensen, Anne Lineen_GB
dc.contributor.authorTuv, Silja Skogstaden_GB
dc.contributor.authorBilgrei, Ola Røeden_GB
dc.contributor.authorFjeld, Benteen_GB
dc.contributor.authorBachs, Lilianaen_GB
dc.identifier.citationBretteville-Jensen AL, Tuv SS, Bilgrei OR,Fjeld B, Bachs L: Synthetic cannabinoids and cathinones: Prevalence and markets; Forensic sci rev 25:7;2013-
dc.description.abstractOver the past few years, the phenomenon of new designer drugs has attracted much attention. Synthetic cannabinoids and cathinones are the two main classes of these drugs. Both are potent drugs of abuse, and several cases of severe toxicity and deaths are reported. The present work is based on a systematic review of studies that have assessed the market and prevalence of synthetic cannabinoids and cathinones, and integrates pharmacological, sociological, and epidemiological aspects of these two groups of emerging synthetic drugs. The review refl ects that the Internet has made synthetic cannabinoids and cathinones widely available. Furthermore, aggressive and widespread marketing, as well as the low price level of these drugs, their juridical status and their lack of detection on standard drug tests may serve as major motivations for drug use. The number of prevalence studies is small and derived from a limited number of countries. In spite of the many methodological shortcomings, some conclusions may be cautiously drawn. Taken together, the results point toward higher prevalence of use for synthetic cathinones than for synthetic cannabinoids. In the general population, the prevalence of use of synthetic cathinones is reported to be around 4% compared to fi gures lower than 1% for synthetic cannabinoids. Among students, the prevalence varies from 1–20% for synthetic cathinones and 2–10% for synthetic cannabinoids. Among groups with high rates of drug use, the prevalence varies between 4% to more than 60% for synthetic cathinones and around 10% for synthetic cannabinoids.-
dc.titleSynthetic cannabinoids and cathinones: prevalence and markets-
dc.typeJournal articleen
dc.typepeer revieweden
dc.contributor.departmentNorwegian Institute of Public Healthen_GB
dc.identifier.journalForensic Science Review-
All Items in HeRA are protected by copyright, with all rights reserved, unless otherwise indicated.